Entity type
Company
Filer Snapshot
GILEAD SCIENCES, INC.
CIK 0000882095. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
198
Latest filing
27 May 2026
Industry
Biological Products, (No Disgnostic Substances)
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
$2.12B
6 holdings for Q1 2026
Open portfolioLargest parsed holding
ACLX
$771.68M reported value
Open holding13D/G large stake
ASMB
22 May 2026 · 25% ownership
Open 13D/GInsider / owner context
ACLX
28 Dec 2023 · $371.44M
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Schedule 13D/G
View Source Filing
SCHEDULE 13D/A filed on 27 May 2026 for CIK 0000882095.
- Ticker symbols
- GILD on Nasdaq
- Ownership signals
-
SEC value by filing type
Compare filing types separately; 13F, 13D/G, and Forms 3/4/5 are different evidence sources.
Latest 13F portfolio$2.12BQuarterly institutional portfolio holdings.
Forms 3/4/5 positions$916.75MReporting-owner positions with enough data to estimate value.
Latest 13F portfolio value
$2.12BMarket value from the latest parsed Form 13F portfolio.
Estimated Forms 3/4/5 position value
$916.75MEstimated only when owner filings include enough share and price data.
Largest 13F positions
ACLX RCUS GLPG ASMB KYTX+1 more
XLOLargest symbols in the latest parsed 13F information table.
Largest linked SEC positions
Largest issuer positions found across parsed 13F, 13D/G, and Forms 3/4/5 data.
ACLX RCUS ASMB XLO LPTX HOOK ALVRLargest 13F positions
Largest symbols in the latest parsed Form 13F information table.
ACLX RCUS GLPG ASMB KYTX XLOSchedule 13D positions
Active large-stake positions disclosed in parsed Schedule 13D filings.
GLPG ACLX RCUS ASMBSchedule 13G positions
Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.
XLO KLRS IKNA CYPHHow to read these SEC values
- Read each filing type on its own: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different questions.
- Open the linked research paths when you need to verify the exact SEC filing behind a value.
- Business address
- 333 Lakeside Dr, Foster City, CA, 94404
- State of incorporation
- DE
- Fiscal year-end
- 31 December
Ownership signals
1 signal
Identity
2 identity fields
SEC profile 2 profile fields
Filer intelligence
What SEC filings say about GILEAD SCIENCES, INC.
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Latest parsed 13F shows $2.12B across 6 reported holdings for Q1 2026.
- Largest parsed 13F holding: ACLX at $771.68M.
- 5 recent 13D/G stake rows found; top row is ASMB at 25% ownership.
- Forms 3/4/5 show insider context for ACLX worth $371.44M.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Top parsed 13F holdings
Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.
Top 5 concentration
100%
Share of latest parsed 13F value represented by the visible holdings below.
Top 5 reported value
$2.11B
Compared with $2.12B total 13F value.
Top 5 net change
$0
Position-value change inside the visible top holdings only.
13F concentration map
A simple visual split of the latest parsed 13F portfolio.
Largest trim: XLO
ACLX
RCUS
GLPG
ASMB
KYTX
Other holdings
13D/G large-stake context
ASMB
22 May 2026 · Common Stock, par value $0.001
ACLX
28 Apr 2026 · Common Stock, par value $0.001
XLO
31 Dec 2025 · Common Stock, par value $0.0001 per share
CYPH
31 Dec 2025 · Common Stock, par value $0.001 per share
Forms 3/4/5 insider context
ACLX
28 Dec 2023 · 10% owner
RCUS
18 Feb 2025 · 10% owner
ASMB
26 May 2026 · 10% owner
XLO
13 Feb 2026 · 10% owner
Latest update
What changed recently for GILEAD SCIENCES, INC.
Latest ownership report period: 26 May 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
27 May 2026
Page type
Ownership filings
Latest period
26 May 2026
Ownership context was refreshed from SEC Forms 3/4/5 filed on 27 May 2026.
Benchmark Context
Benchmark context for this company
GILEAD SCIENCES, INC. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest ownership report period: 26 May 2026. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 07 May 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0000882095 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
198
First seen
29 Dec 2023
Latest filing
27 May 2026
Entity
Company
Observed form types
10-K
10-Q
13F-HR
3
4
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G/A
Industry context: Biological Products, (No Disgnostic Substances).
Latest Filings
Showing the latest 12 of 198 SEC filings for GILEAD SCIENCES, INC..
SCHEDULE 13D/A
SCHEDULE 13D/A filing
- Filing date
- 27 May 2026
- Reporting date
- Not listed
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 May 2026
- Reporting date
- 15 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 May 2026
- Reporting date
- 15 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
13F-HR
13F-HR filing
- Filing date
- 08 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-Q
10-Q filing
- Filing date
- 07 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 30 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing